News

Filter

Current filters:

Procrit

1 to 9 of 281 results

US FDA modifies dosing for ESA’s Aranesp, Epogen and Procrit on cardiovascular risks

27-06-2011

The US Food and Drug Administration on Friday recommended more conservative dosing guidelines for erythropoiesis-stimulating…

AmgenAranespBiotechnologyEpogenJohnson & JohnsonNorth AmericaOncologyPharmaceuticalProcritRegulation

New guideline from ASH and ASCO recommends caution regarding ESA use in cancer patients

28-10-2010

An updated joint guideline by the American Society of Hematology (ASH) and the American Society of Clinical…

AmgenAranespBiotechnologyEpogenImmunologicalsJohnson & JohnsonOncologyPharmaceuticalProcritRegulation

Changes brewing in the US renal anemia market, suggest reports from BioTrends

28-04-2010

clinical trial TREAT has increased and around 90% of nephrologists are at least somewhat familiar with…

AmgenAranespCentocor Ortho BiotechEpogenMarkets & MarketingNorth AmericaOncologyPharmaceuticalProcrit

1 to 9 of 281 results

COMPANY SPOTLIGHT

Menarini

Back to top